Bayer reveals data behind asundexian's stroke win Bayer's oral Factor XIa inhibitor asundexian can reduce the risk of a secondary ischaemic stroke by 26%, according to the OCEANIC-STROKE trial

#Bayer #asundexian #stroke #oralFactorXIainhibitor #FactorXIainhibitor #ischaemicstroke #OCEANICSTROKEstudy #antiplatelettherapy #InternationalStrokeConference #phase3trial #secondarystrokeprevention #anticlottingtherapies #OCEANICSTROKE #acutecoronarysyndromes #preventionofstroke
zurl.co/Mhc1J

Join Dr. Max Smith and Amanda Hanson on October 7th 1 PM EST/7 PM CET to discuss #CYP2C19 genotype-guided #AntiplateletTherapy & #Pharmacogenomics in #PatientCare.​
🔗Register: t.co/cujTqGccpf
#MedSky #MedX #Neuro #RapidCYP2C19 #CardioSky #DAPT #Cardio #FastCYP2C19 #RapidTesting

Redirecting...

www.facebook.com/share/p/1DLA...
Register for our upcoming educational webinar with Dr. Max Smith and Amanda Hanson on Oct 7th 1 PM EST/7 PM CET to discuss #CYP2C19 genotype-guided #AntiplateletTherapy to optimize #PatientCare.​
Register: t.co/cujTqGccpf
#MedSky #RapidCYP2C19 #DAPT

Join Dr. Max Smith and Amanda Hanson on October 7th 1 PM EST/7 PM CET to discuss #CYP2C19 genotype-guided #AntiplateletTherapy & #Pharmacogenomics in #PatientCare.​
🔗Register: whitehatevents.webex.com/weblink/regi...
#MedSky#MedX#Neuro #RapidCYP2C19 #CardioSky#DAPT#Cardio #FastCYP2C19 #RapidTesting

The study explores the effects of discontinuing P2Y12 receptor inhibitors before undergoing isolated on-pump coronary artery bypass grafting (CABG). #AntiplateletTherapy #BleedingRisk #CardiovascularSurgery #Coronaryarterybypassgrafting #MetaAnalysis #P2Y12Inhibitors
bit.ly/4jJY4sp

The DAPT-SHOCK-AMI trial compared cangrelor vs. crushed ticagrelor in AMI with #cardiogenicshock, focusing on 30-day major cardiovascular outcomes to guide high-risk patient care.
ow.ly/Xk1l50TRO3r #AntiplateletTherapy